With a market capitalization (market cap) of $2.4B — a measure of how much the company is worth — Prestige Consumer Healthcare Inc. is the 1979th most valuable company in Healthcare as of August 19, 2026. Shares trade at $50.57, up +1.06% on the day.
of 2,587
price ÷ annual EPS
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
Prestige Consumer Healthcare Inc., along with its various divisions, is involved in the creation, production, promotion, and distribution of non-prescription health and personal care items across both domestic (U.S.) and global markets. The company's business activities are structured into two principal areas: North American Over-the-Counter Healthcare and International Over-the-Counter Healthcare. Their extensive brand catalog features a diverse array of consumer health solutions, including popular choices for pain relief (such as BC/Goody's), infant care (Boudreaux's Butt Paste), sore throat remedies (Chloraseptic), vision care (Clear Eyes, TheraTears), wart treatment (Compound W), dental hygiene (DenTek), earwax removal (Debrox), and motion sickness prevention (Dramamine). The product line further extends to include digestive aids (Fleet, Gaviscon), cough suppressants (Luden's), feminine hygiene items (Monistat, Summer's Eve), treatments for lice and parasites (Nix), nasal washes (Fess), and rehydration therapies (Hydralyte). These offerings reach consumers through a wide range of retail channels, such as large discount retailers, pharmacies, supermarkets, dollar stores, convenience outlets, membership-based clubs, and digital commerce platforms. Founded in 1996 and based in Tarrytown, New York, the organization operated under the name Prestige Brands Holdings, Inc. until its rebranding to Prestige Consumer Healthcare Inc. in August 2018.
Visit websiteAs of August 19, 2026, Prestige Consumer Healthcare Inc. (PBH) is worth $2.4B — this is its market capitalization, the total value of all its outstanding shares.
Prestige Consumer Healthcare Inc.’s market cap is $2.4B, which ranks it #1979 among the most valuable companies in the Healthcare sector tracked on MarketCapLens.
Prestige Consumer Healthcare Inc. (PBH) shares trade at $50.57, up 1.06% on the day, as of August 19, 2026.
Fundamentals are annual. Figures labeled with their fiscal year.
FY 2026
Prestige Consumer Healthcare Inc. trades at a price-to-earnings (P/E) ratio of 12.9, based on its latest share price and annual earnings per share.